SAS Institute, Inc. - Global

Growing development and demand for high value biopharmaceuticals, vaccines and gene therapy products including increasingly complex global clinical trials face ever increasing regulatory and security requirements related to the integrity of the current global cold chain logistics model. This dynamic situation makes it very difficult to monitor, track and optimize biologics logistics, resulting in a lack end-to-end transparency which can create regulatory compliance issues and risks to patient safety.

To address the global challenges of the current Cold Chain logistics model, SAS' Cold Chain Integrity solution provides monitoring, tracking and optimizing capabilities to help companies harness the highly dimensional and complex nature of biologics logistics.

Maintaining the integrity and addressing the efficiency of cold chain management for biologic products and especially vaccines necessitates three key capabilities:

The ability to provide continuous and reliable monitoring of the cold chain across delivery and storage and handling, thus enabling end-to-end transparency for key assets and drive data-enabled action across the supply chain
The ability to track the product of interest from the first step of distribution to its ultimate administration to a patient. This ensures that guidelines and protocols are followed for distribution / storage while maintaining the integrity of the supply chain for regulatory compliance and patient safety
Building upon the tenants of monitoring and tracking the ability to optimize across the entire supply chain, providing continuous situational awareness and the ability to maximize efficiency and supply and demand alignment and minimize waste fraud and spoilage.

Cold Chain IntegritySAS Institute Inc.

Cold Chain Integrity

SAS Institute Inc.

Cold Chain Integrity

SAS Institute Inc.

Cold Chain Integrity
SAS Institute Inc.